LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Alkeus Pharmaceuticals Inc.
Headquarters:
Boston, MA, United States of America
Website:
http://www.alkeus.com
Year Founded:
N/A
Status:
Private
BioCentury
|
Nov 8, 2024
Management Tracks
Moderna expands executive committee, moves commercial under Hoge
Plus: New CFOs at Alkeus, ClaciMedica, and updates from Clairity and Kincell
Read More
BioCentury
|
Jul 16, 2024
Management Tracks
Nadir Mahmood returning to Nkarta
Plus: Perry Sternberg named CEO of Sydnexis, and updates from SFA, Alkeus and Optibrium
Read More
BioCentury
|
Jul 3, 2024
Management Tracks
Dahan succeeds Saad as Alkeus CEO
Plus: Fox becomes interim CEO of Alphina and updates from Inovio and BenevolentAI
Read More
BioCentury
|
Jun 1, 2024
Management Tracks
Verve promotes Lister to CSO
Plus: Quantum-Si appoints Kummeth independent chair and updates from Alkeus and SAB
Read More
BioCentury
|
Jan 25, 2024
Management Tracks
Moeller named CEO of BenevolentAI
Plus: new CFO at Orion and updates from Alkeus and Immorta
Read More
BioCentury
|
Jun 5, 2023
Product Development
Highlights from ASCO: a BioCentury Podcast
The IRA and cancer drugs, plus readouts from ADCs, BCMA therapies and more
Read More
BioCentury
|
Jun 5, 2023
Product Development
As Vertex founder Boger returns, long-simmering Alkeus draws $150M for Stargardt program
After subsisting for more than a decade on very little cash, tiny biotech believes registrational data point way to building a larger company
Read More
BioCentury
|
Oct 21, 2013
Politics & Policy
FDA awards over $14M in grants for rare diseases
Read More
BioCentury
|
May 28, 2012
Company News
Alkeus board of directors update
Read More
BioCentury
|
May 24, 2012
Company News
Vertex's Boger joins eye company Alkeus
Read More
Items per page:
10
1 - 10 of 10